PAK1 and glioblastoma: AKT is a key molecule of the PI3K pathway, and thus we focused on the impact of the interaction between PAK1 and AKT1 on GBM cells, and the effect of PAK1 inhibitors on the occurrence and development of GBM [52, 53].